申请人:Lilly Industries Limited
公开号:US05514699A1
公开(公告)日:1996-05-07
The invention provides pharmaceutical compounds of the formula: ##STR1## in which A - - - B is CH.sub.2 --CH.sub.2 or CH.dbd.CH; X is a pyridine or benzene ring; when X is pyridine n is 0; when X is benzene n is 0, 1 or 2 and when A - - - B is CH.sub.2 --CH.sub.2, R.sup.1 is attached at any of the positions 7 to 10, and when A - - - B is CH.dbd.CH, R.sup.1 is attached at any of the positions 5 to 10; and salts thereof.
该发明提供了具有以下结构的药物化合物:##STR1## 其中A-B为CH2-CH2或CH=CH;X为吡啶或苯环;当X为吡啶时,n为0;当X为苯时,n为0、1或2;当A-B为CH2-CH2时,R1连接在位置7至10中的任意位置;当A-B为CH=CH时,R1连接在位置5至10中的任意位置;以及其盐。